La cirugía para perder peso podría reducir el riesgo de padecer ciertos tipos de cáncer sanguíneo
MARTES, 26 de septiembre de 2023 (HealthDay News) — La cirugía para perder peso puede ofrecer una serie de beneficios para la salud, pero una nueva investigación revela uno inesperado: someterse a la cirugía se asoció con un 40% menos de riesgo de cán…
Learn MoreFamily History Influences Penetrance of Hereditary Cancers
MONDAY, Sept. 25, 2023 (HealthDay News) — For individuals with a pathogenic variant in the major genes responsible for hereditary breast cancer or Lynch syndrome, having a first-degree family history is associated with increased cancer risk, accordin…
Learn MoreMany Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia
MONDAY, Sept. 25, 2023 (HealthDay News) — For patients with metastatic breast cancer receiving the PI3K inhibitor alpelisib, hyperglycemia often occurs, with a median time to onset of 16 days, according to a study published online Sept. 25 in Cancer….
Learn MoreExercise Intervention Has Biological Effect in Lynch Syndrome
MONDAY, Sept. 25, 2023 (HealthDay News) — An exercise intervention has biological effects on the immune system among patients with Lynch syndrome (LS), according to a study published online Sept. 19 in Clinical Cancer Research.Nan Deng, from The Univ…
Learn MoreBreast Cancer Drug Could Trigger Dangerous High Blood Sugar
MONDAY, Sept. 25, 2023 (HealthDay News) — For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.“This is a very …
Learn MoreIncreased Exposure to PFAS, Phenols Linked to Prior Cancer Diagnosis
MONDAY, Sept. 25, 2023 (HealthDay News) — Per- and polyfluoroalkyl substances (PFAS), phenols, and parabens are associated with a previous cancer diagnosis, according to a study published online Sept. 18 in the Journal of Exposure Science & Environme…
Learn MoreCombo Immunotherapy With Durvalumab Effective for NSCLC
MONDAY, Sept. 25, 2023 (HealthDay News) — For patients with resectable non-small cell lung cancer (NSCLC), combination immunotherapy with the anti-programmed death-ligand 1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab …
Learn MoreWeight-Loss Surgery Could Lower Odds for Blood Cancers
MONDAY, Sept. 25, 2023 (HealthDay News) — Weight-loss surgery can deliver a host of health benefits, but new research reveals an unexpected one: Getting the surgery was associated with a 40% lower risk of blood cancers.Being overweight or obese is a …
Learn MoreGood Oral Health Linked to Improved Survival in Head & Neck Cancer
FRIDAY, Sept. 22, 2023 (HealthDay News) — For patients with head and neck squamous cell carcinoma, good oral health is associated with improved survival, according to a study published online Sept. 19 in the Journal of the National Cancer Institute.J…
Learn MoreLa FDA debe tomar medidas enérgicas contra minoristas que venden tabaco a adolescentes: informe
VIERNES, 22 de septiembre de 2023 (HealthDay News) — Un nuevo informe gubernamental concluye que los reguladores federales necesitan hacer más para ayudar en la lucha para mantener a los niños y adolescentes alejados del tabaco.Entre los hallazgos de…
Learn More